{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:16:43Z","timestamp":1769303803352,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtct.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T06:04:49Z","timestamp":1756101889000},"page":"1010-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral Blood Tumor Associated Cell-Free DNA Testing as a Predictor for Relapse Postallogeneic Stem Cell Transplant for Acute Myelogenous Leukemia"],"prefix":"10.1016","volume":"31","author":[{"given":"Vanisha","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0895-1869","authenticated-orcid":false,"given":"Maciej","family":"Kabat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-5618","authenticated-orcid":false,"given":"Andrew","family":"Ip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Chan","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vesole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-5849","authenticated-orcid":false,"given":"Michele","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Albitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3299-835X","authenticated-orcid":false,"given":"Scott D.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtct.2025.08.010_bib0001","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jama.2023.1363","article-title":"DNA sequencing to detect residual disease in adults with acute myeloid leukemia prior to hematopoietic cell transplant","volume":"329","author":"Dillon","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jtct.2025.08.010_bib0002","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in acute myeloid leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jtct.2025.08.010_bib0003","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/cancers15020438","article-title":"Molecular landscape and validation of new genomic classification in 2668 adult AML patients: real life data from the PETHEMA registry","volume":"15","author":"Sargas","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.jtct.2025.08.010_bib0004","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.08.010_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.08.010_bib0007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.2016.159343","article-title":"Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis","volume":"102","author":"Buckley","year":"2017","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.jtct.2025.08.010_bib0008","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/bmt.2016.167","article-title":"Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT","volume":"51","author":"Tsirigotis","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.08.010_bib0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/cancers17040625","article-title":"cfDNA chimerism and somatic mutation testing in early prediction of relapse after allogeneic stem cell transplantation for myeloid malignancies","volume":"17","author":"Rowley","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jtct.2025.08.010_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2025.08.010_bib0011","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/ejh.12925","article-title":"Cell-free DNA\u2014minimally invasive marker of hematological malignancies","volume":"99","author":"Kubaczkova","year":"2017","journal-title":"Eur J Haematol"},{"issue":"16","key":"10.1016\/j.jtct.2025.08.010_bib0012","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/bloodadvances.2023010416","article-title":"Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes","volume":"7","author":"Pasca","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.08.010_bib0023","unstructured":"Hematology profile plus | 302 DNA genes and >1600 RNA genes.https:\/\/genomictestingcooperative.com\/genomic-tests\/gtc-hematology-profile-plus\/(Accessed 2025-04-07)."},{"issue":"26","key":"10.1016\/j.jtct.2025.08.010_bib0014","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.08.010_bib0016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1705582","article-title":"Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia","volume":"39","author":"Huisman","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10.1016\/j.jtct.2025.08.010_bib0017","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.2019003079","article-title":"Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation","volume":"135","author":"Boettcher","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.08.010_bib0018","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3390\/cancers15082305","article-title":"Myeloid NGS analyses of paired samples from bone marrow and peripheral blood yield concordant results: a prospective cohort analysis of the AGMT study group","volume":"15","author":"Jansko-Gadermeir","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jtct.2025.08.010_bib0019","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/s41467-023-37592-9","article-title":"Oncogenic drivers dictate immune control of acute myeloid leukemia","volume":"14","author":"Austin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2025.08.010_bib0020","unstructured":"Patient-specific measurable residual disease markers predict outcome in patients with myelodysplastic syndrome and related diseases after hematopoietic stem-cell transplantation. J Clin Oncol.10.1200\/JCO.23.01159 (Accessed 2025-03-11)."},{"issue":"suppl 1","key":"10.1016\/j.jtct.2025.08.010_bib0021","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood-2023-185243","article-title":"Dynamic changes in pre- and 3 months post-transplant NGS MRD status may predict the allogeneic stem cell transplant outcome of patients with AML","volume":"142","author":"Suh","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.08.010_bib0022","first-page":"14","article-title":"New methods for the quantification of mixed chimerism in transplantation","author":"Picard","year":"2023","journal-title":"Front Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725013764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725013764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:14:57Z","timestamp":1764940497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725013764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666636725013764"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.08.010","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral Blood Tumor Associated Cell-Free DNA Testing as a Predictor for Relapse Postallogeneic Stem Cell Transplant for Acute Myelogenous Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}